Stockport, United Kingdom

Mathew Donnelly

This inventor holds 2 USPTO granted patents. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2018-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mathew Donnelly. Retrieved from https://idiyas.com/inventor/mathew-donnelly

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 2

Forward Citations = 119(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mathew Donnelly: Innovator in Pharmaceutical Technology

Introduction

Mathew Donnelly is a notable inventor based in Stockport, GB. He has made significant contributions to the field of pharmaceutical technology, particularly with his innovative designs. With a total of 2 patents to his name, Donnelly continues to push the boundaries of medical advancements.

Latest Patents

One of Mathew Donnelly's latest inventions is the injector pen. This device is designed to improve the delivery of medication, making it more accessible and user-friendly for patients. His work in this area reflects his commitment to enhancing healthcare solutions.

Career Highlights

Donnelly is currently employed at Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role there allows him to collaborate with other experts in the field and contribute to the development of innovative medical products.

Conclusion

Mathew Donnelly's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the development of the injector pen, highlight his dedication to improving patient care and advancing medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…